Novavax, Inc.
NVAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$187,499 | -$545,062 | -$657,939 | -$1,743,751 |
| Dep. & Amort. | $48,496 | $41,225 | $29,054 | $12,661 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $48,152 | $85,357 | $130,300 | $183,626 |
| Change in WC | $48,482 | -$376,836 | -$361,150 | $1,733,618 |
| Other Non-Cash | -$44,894 | $81,349 | $443,798 | $136,792 |
| Operating Cash Flow | -$87,263 | -$713,967 | -$415,937 | $322,946 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14,639 | -$58,806 | -$92,985 | -$57,486 |
| Net Acquisitions | $192,643 | $0 | $0 | $57,486 |
| Inv. Purchases | -$825,593 | $0 | $0 | -$2,167 |
| Inv. Sales/Matur. | $443,551 | $0 | $0 | $159,807 |
| Other Inv. Act. | $0 | $0 | $0 | -$57,486 |
| Investing Cash Flow | -$204,038 | -$58,806 | -$92,985 | $100,154 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,994 | -$352,345 | $81,655 | -$127,907 |
| Stock Issued | $263,272 | $360,243 | $249,230 | $564,859 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,305 | -$3,432 | -$5,897 | $24,761 |
| Financing Cash Flow | $260,583 | $4,466 | $324,988 | $461,713 |
| Forex Effect | -$7,800 | $3,272 | $4,520 | -$5,292 |
| Net Chg. in Cash | -$38,518 | -$765,035 | -$179,414 | $879,521 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $583,810 | $1,348,845 | $1,528,259 | $648,738 |
| End Cash | $545,292 | $583,810 | $1,348,845 | $1,528,259 |
| Free Cash Flow | -$100,320 | -$772,773 | -$508,922 | $265,460 |